Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Nutr.

Sec. Nutritional Immunology

This article is part of the Research TopicRole of Short-Chain Fatty Acids in Inflammation and Immune FunctionView all articles

Fecal Short-Chain Fatty Acids and Serum Metabolites: The Impact of COVID-19 Infection on Dialysis Patients

Provisionally accepted
Jiamin  DuanJiamin DuanJing  ZhangJing ZhangChanglin  LiChanglin LiYuting  LiYuting LiDuo  YuDuo YuYuwei  ChenYuwei ChenQingli  YangQingli YangXiaomeng  LinXiaomeng Lin*Xudong  CaiXudong Cai*
  • Ningbo Hospital of Traditional Chinese Medicine, Ningbo, China

The final, formatted version of the article will be published soon.

Introduction: Patients undergoing dialysis are particularly susceptible to severe COVID-19 outcomes owing to pre-existing metabolic and immunological dysregulation, which may exacerbate clinical severity and elevate the risk of long COVID (LC). Nevertheless, the precise metabolic pathways implicated remain poorly characterized. This study aimed to characterize fecal short-chain fatty acids (SCFAs) and serum metabolomic signatures in dialysis patients with acute COVID-19 and to explore their association with LC. Methods: Targeted liquid chromatography–tandem mass spectrometry (LC–MS/MS) quantified fecal SCFAs in 27 infected patients and 28 non-infected controls, and untargeted gas chromatography–mass spectrometry (GC–MS)-based metabolomics profiled serum samples from 23 infected patients and all 40 controls in partially overlapping patient subsets, with repeat serum sampling at 3 months and stratification into LC and non-LC groups. Multivariate analyses, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, and Pearson correlation analyses between differential metabolites and routine clinical indicators were performed. Results: Infected patients exhibited significantly lower fecal levels of six SCFAs, including propionate and butyrate, compared with controls. Serum metabolomics identified 54 infection-related differential metabolites enriched in amino acid, energy, carbohydrate, and nucleotide metabolism, and 77 LC-associated metabolites predominantly mapping to amino acid and energy pathways. Pearson correlation analysis showed that amino acids and energy-supporting metabolites (e.g., glutamine, aspartate, methionine, cystine, taurine) were inversely correlated with C-reactive protein , leukocyte and neutrophil counts, and aspartate aminotransferase, but positively correlated with albumin, serum potassium, and lymphocyte or eosinophil counts, whereas purine degradation products and organic acids (e.g., uric acid, hypoxanthine, pyruvate, glycolate) exhibited the opposite pattern. Discussion: COVID-19 infection in dialysis patients is associated with marked depletion of fecal SCFAs and broad perturbations of systemic metabolism, with persistent amino-acid–centered alterations among patients who develop LC.These findings offer a novel metabolic framework supporting the implementation of prolonged follow-up strategies to monitor and ameliorate persistent sequelae in this high-risk population.

Keywords: COVID-19, Dialysis, Long Covid, Metabolomics, short-chain fatty acids

Received: 21 Dec 2025; Accepted: 31 Jan 2026.

Copyright: © 2026 Duan, Zhang, Li, Li, Yu, Chen, Yang, Lin and Cai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Xiaomeng Lin
Xudong Cai

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.